ENG/中
老虎證券
行情
产品介绍
Cash Boost账户
CPF/SRS 投资
新加坡股
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
宜明昂科-B
11.800
-0.530
-4.30%
手動刷新
成交量:
174.54萬
成交額:
2,057.75萬
市值:
48.06億
市盈率:
-12.93
高:
12.400
開:
12.340
低:
11.610
收:
12.330
52周最高:
15.660
52周最低:
3.210
股本:
4.07億
香港流通股本:
3.96億
量比:
0.73
換手率:
0.44%
股息:
- -
股息率:
- -
每股收益(LYR):
-0.913
淨資產收益率:
-44.38%
總資產收益率:
-21.43%
市淨率:
6.50
市盈率(LYR):
-12.93
市銷率:
55.45
資料載入中...
總覽
公司
新聞
公告
宜明昂科-B06月27日遭主力拋售1131.5萬元
市场透视
·
06/27
宜明昂科-B盤中異動 早盤股價大跌5.11%報12.640港元
市场透视
·
06/26
宜明昂科-B06月24日主力淨流入167.1萬元 散户資金拋售
市场透视
·
06/24
港股異動 | 宜明昂科-B(01541)漲超7% IMC-003/IMM72治療肺動脈高壓臨牀試驗獲國家藥監局批准
智通财经
·
06/24
宜明昂科-B盤中異動 股價大跌5.24%報11.940港元
市场透视
·
06/23
宜明昂科-B:IMC-003/IMM72獲國家藥監局批准進行臨牀試驗
格隆汇资讯
·
06/23
宜明昂科-B06月19日主力淨流出319.7萬元 散戶資金買入
市场透视
·
06/19
宜明昂科-B06月18日主力淨流入162.6萬元 散戶資金拋售
市场透视
·
06/18
宜明昂科-B(01541):贖回及認購理財產品
智通财经
·
06/16
宜明昂科-B06月16日主力淨流入216.1萬元 散戶資金拋售
市场透视
·
06/16
宜明昂科-B(01541)股價下跌8.023%,現價港幣$12.84
阿斯达克财经
·
06/13
不在港股通股價也狂飆,PD-(L)1/VEGF雙抗熱潮下,宜明昂科有“幾把刷子”?
Ofweek维科网
·
06/12
宜明昂科-B盤中異動 股價大漲5.03%
市场透视
·
06/12
宜明昂科-B盤中異動 早盤股價大跌5.18%報14.280港元
市场透视
·
06/11
宜明昂科-B(01541):吳諸麗獲委任為首席醫學官
智通财经
·
06/09
宜明昂科-B盤中異動 快速上漲5.39%報14.860港元
市场透视
·
06/09
宜明昂科-B午後漲超9% IMM0306今年有望實現大金額BD IMM2510數據優秀
智通财经
·
06/06
【券商聚焦】國元國際予宜明昂科(01541)買入評級 指CD47CD20雙抗有望成為自免領域重磅藥物
金吾财讯
·
06/06
宜明昂科-B盤中異動 下午盤急速上漲5.18%
市场透视
·
06/06
宜明昂科-B盤中異動 快速拉昇5.02%
市场透视
·
06/05
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/01541/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01541","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01541\",,,,,undefined,":{"symbol":"01541","market":"HK","secType":"STK","nameCN":"宜明昂科-B","latestPrice":11.8,"timestamp":1756195699002,"preClose":12.33,"halted":0,"volume":1745400,"delay":0,"floatShares":396277305,"shares":407307695,"eps":-0.912591054658317,"marketStatus":"已收盤","change":-0.53,"latestTime":"08-26 16:08:19","open":12.34,"high":12.4,"low":11.61,"amount":20577460,"amplitude":0.064071,"askPrice":11.8,"askSize":200,"bidPrice":11.75,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":-0.912591054658317,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1756258200000},"marketStatusCode":5,"adr":0,"listingDate":1693843200000,"exchange":"SEHK","adjPreClose":12.33,"openAndCloseTimeList":[[1756171800000,1756180800000],[1756184400000,1756195200000]],"volumeRatio":0.726778,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01541\",,,,,undefined,":{"symbol":"01541","floatShares":396277305,"roa":"-21.43%","roe":"-44.38%","lyrEps":-0.912591,"volumeRatio":0.726778,"shares":407307695,"dividePrice":0,"high":12.4,"amplitude":0.064071,"preClose":12.33,"low":11.61,"week52Low":3.21,"pbRate":"6.50","psRate":"55.45","week52High":15.66,"institutionHeld":0,"latestPrice":11.8,"committee":0.818182,"eps":-0.912591054658317,"divideRate":0,"volume":1745400,"delay":0,"ttmEps":-0.912591054658317,"open":12.34,"prevYearClose":5.16,"prevWeekClose":12.02,"prevMonthClose":11.02,"prevQuarterClose":12,"fiveDayClose":12.96,"twentyDayClose":11.76,"sixtyDayClose":14.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01541\",params:#limit:5,,,undefined,":[{"date":"2025-08-26","symbol":"01541","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null},{"date":"2025-03-25","symbol":"01541","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742866200000,"name":null,"time":"盤後","dateTimestamp":1742832000000,"actualEps":null},{"market":"HK","date":"2024-08-26","symbol":"01541","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1724601600000,"reportTimeType":"post","actualEps":null},{"date":"2024-03-25","symbol":"01541","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01541\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01541\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1697558400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01541\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01541","date":"2025-08-25","current":-14.555161,"percent":0.328542,"low":-30.003263,"twenty":-22.665631,"median":-13.01303,"eighty":-6.054191,"high":-2.993766,"avg":-13.617797,"sd":7.665432,"marketCap":5022103879},"quantilePoints":[{"date":"2023-08-31","current":-17.746094,"twenty":-17.746094,"median":-17.746094,"eighty":-17.746094,"marketCap":6942262047},{"date":"2023-09-08","current":-19.116691,"twenty":-19.083294,"median":-18.655615,"eighty":-17.801139,"marketCap":7390149921},{"date":"2023-09-15","current":-24.765877,"twenty":-24.765877,"median":-19.116691,"eighty":-18.557812,"marketCap":9648251285},{"date":"2023-09-22","current":-25.548224,"twenty":-25.200205,"median":-24.360534,"eighty":-18.753419,"marketCap":9909519212},{"date":"2023-09-29","current":-29.804324,"twenty":-26.447668,"median":-24.870232,"eighty":-19.083294,"marketCap":11580180660},{"date":"2023-10-06","current":-24.76052,"twenty":-26.458287,"median":-24.870232,"eighty":-19.110012,"marketCap":9615852761},{"date":"2023-10-13","current":-27.113287,"twenty":-26.458287,"median":-25.206314,"eighty":-22.322253,"marketCap":10513831229},{"date":"2023-10-20","current":-26.768577,"twenty":-26.795293,"median":-25.37532,"eighty":-23.788881,"marketCap":10364168151},{"date":"2023-10-27","current":-28.665306,"twenty":-27.124745,"median":-25.753577,"eighty":-24.00727,"marketCap":11093775656},{"date":"2023-11-03","current":-26.275244,"twenty":-27.500238,"median":-26.158488,"eighty":-24.473108,"marketCap":10195797188},{"date":"2023-11-10","current":-26.039628,"twenty":-27.37617,"median":-26.041732,"eighty":-24.763734,"marketCap":10102257765},{"date":"2023-11-17","current":-26.714897,"twenty":-27.225983,"median":-26.171076,"eighty":-24.792429,"marketCap":10457707575},{"date":"2023-11-24","current":-27.539565,"twenty":-27.37617,"median":-26.271304,"eighty":-24.846191,"marketCap":10869281039},{"date":"2023-12-01","current":-28.464343,"twenty":-27.564693,"median":-26.306056,"eighty":-24.874164,"marketCap":11280854504},{"date":"2023-12-08","current":-27.67933,"twenty":-27.70336,"median":-26.447668,"eighty":-25.070837,"marketCap":10925404694},{"date":"2023-12-15","current":-27.708906,"twenty":-27.817253,"median":-26.526325,"eighty":-25.207536,"marketCap":11000236233},{"date":"2023-12-22","current":-27.916049,"twenty":-27.937914,"median":-26.714897,"eighty":-25.244891,"marketCap":11075067772},{"date":"2023-12-29","current":-28.049426,"twenty":-27.986303,"median":-26.835368,"eighty":-25.288293,"marketCap":11187315080},{"date":"2024-01-05","current":-23.146888,"twenty":-27.970711,"median":-26.68937,"eighty":-25.200205,"marketCap":9166863527},{"date":"2024-01-12","current":-26.439512,"twenty":-27.935571,"median":-26.500765,"eighty":-25.200205,"marketCap":10476415460},{"date":"2024-01-19","current":-25.435754,"twenty":-27.916049,"median":-26.490281,"eighty":-25.212424,"marketCap":10064841995},{"date":"2024-01-26","current":-23.636611,"twenty":-27.83997,"median":-26.442842,"eighty":-24.972615,"marketCap":9316526605},{"date":"2024-02-02","current":-21.195554,"twenty":-27.817533,"median":-26.372788,"eighty":-24.783518,"marketCap":8343716598},{"date":"2024-02-09","current":-18.727145,"twenty":-27.802108,"median":-26.275244,"eighty":-24.041989,"marketCap":7408322361},{"date":"2024-02-16","current":-17.739662,"twenty":-27.801452,"median":-26.252628,"eighty":-23.794995,"marketCap":7019198358},{"date":"2024-02-23","current":-22.387155,"twenty":-27.764049,"median":-26.165159,"eighty":-23.13759,"marketCap":8811413717},{"date":"2024-03-01","current":-17.708555,"twenty":-27.735275,"median":-26.04068,"eighty":-22.460898,"marketCap":6974299434},{"date":"2024-03-08","current":-19.229551,"twenty":-27.718352,"median":-26.025076,"eighty":-21.141323,"marketCap":7576693323},{"date":"2024-03-15","current":-16.157629,"twenty":-27.69116,"median":-25.695795,"eighty":-19.998834,"marketCap":6360680815},{"date":"2024-03-22","current":-15.411367,"twenty":-27.66021,"median":-25.548224,"eighty":-19.057216,"marketCap":6061354659},{"date":"2024-03-28","current":-14.696214,"twenty":-27.629432,"median":-25.408294,"eighty":-18.737655,"marketCap":6038905197},{"date":"2024-04-05","current":-13.011166,"twenty":-27.602384,"median":-25.364375,"eighty":-18.557812,"marketCap":5342971884},{"date":"2024-04-12","current":-13.094845,"twenty":-27.539565,"median":-25.225009,"eighty":-18.239836,"marketCap":5380387654},{"date":"2024-04-19","current":-13.014894,"twenty":-27.51439,"median":-25.154554,"eighty":-17.708555,"marketCap":5342971884},{"date":"2024-04-26","current":-13.779237,"twenty":-27.443648,"median":-24.972615,"eighty":-16.602696,"marketCap":5649781194},{"date":"2024-05-03","current":-12.839078,"twenty":-27.434442,"median":-24.870232,"eighty":-16.184677,"marketCap":5260657191},{"date":"2024-05-10","current":-13.282389,"twenty":-27.357513,"median":-24.774698,"eighty":-14.702373,"marketCap":5455219193},{"date":"2024-05-17","current":-13.228926,"twenty":-27.225983,"median":-24.581805,"eighty":-14.243189,"marketCap":5425286577},{"date":"2024-05-24","current":-13.350651,"twenty":-27.145452,"median":-23.955191,"eighty":-13.966896,"marketCap":5462702347},{"date":"2024-05-31","current":-13.410156,"twenty":-27.124745,"median":-23.750163,"eighty":-13.747349,"marketCap":5492634962},{"date":"2024-06-07","current":-14.158514,"twenty":-27.039336,"median":-23.288627,"eighty":-13.645876,"marketCap":5791961118},{"date":"2024-06-14","current":-13.347574,"twenty":-26.971042,"median":-23.123643,"eighty":-13.527845,"marketCap":5455219193},{"date":"2024-06-21","current":-13.283836,"twenty":-26.926395,"median":-22.448608,"eighty":-13.452996,"marketCap":5417803423},{"date":"2024-06-28","current":-12.683619,"twenty":-26.848726,"median":-21.974147,"eighty":-13.40419,"marketCap":5170859344},{"date":"2024-07-05","current":-11.291057,"twenty":-26.759122,"median":-21.059976,"eighty":-13.359292,"marketCap":4602139648},{"date":"2024-07-12","current":-12.246119,"twenty":-26.720023,"median":-20.206581,"eighty":-13.323498,"marketCap":4998746805},{"date":"2024-07-19","current":-11.915911,"twenty":-26.704686,"median":-19.229551,"eighty":-13.282563,"marketCap":4864050035},{"date":"2024-07-26","current":-11.780484,"twenty":-26.652155,"median":-19.050696,"eighty":-13.224977,"marketCap":4826634265},{"date":"2024-08-02","current":-13.633124,"twenty":-26.594701,"median":-18.753419,"eighty":-13.20236,"marketCap":5582432809},{"date":"2024-08-09","current":-9.567144,"twenty":-26.54166,"median":-18.630761,"eighty":-13.102374,"marketCap":3943622105},{"date":"2024-08-16","current":-8.483685,"twenty":-26.496571,"median":-18.451463,"eighty":-13.086665,"marketCap":3498374448},{"date":"2024-08-23","current":-8.095604,"twenty":-26.47337,"median":-18.020488,"eighty":-13.035717,"marketCap":3352452947},{"date":"2024-08-30","current":-7.377309,"twenty":-26.446703,"median":-17.739662,"eighty":-12.990136,"marketCap":3034418906},{"date":"2024-09-06","current":-4.227864,"twenty":-26.442176,"median":-17.681919,"eighty":-12.840212,"marketCap":1739833281},{"date":"2024-09-13","current":-4.503325,"twenty":-26.43833,"median":-16.602696,"eighty":-12.741292,"marketCap":1848339013},{"date":"2024-09-20","current":-4.539912,"twenty":-26.433601,"median":-16.202037,"eighty":-12.246119,"marketCap":1874530051},{"date":"2024-09-27","current":-5.476578,"twenty":-26.311976,"median":-15.844451,"eighty":-11.915911,"marketCap":2274878785},{"date":"2024-10-04","current":-6.596451,"twenty":-26.302504,"median":-15.05764,"eighty":-11.832338,"marketCap":2727609596},{"date":"2024-10-10","current":-5.983695,"twenty":-26.285201,"median":-14.496802,"eighty":-11.807116,"marketCap":2458216056},{"date":"2024-10-18","current":-5.191078,"twenty":-26.27288,"median":-14.209972,"eighty":-11.719903,"marketCap":2121474130},{"date":"2024-10-25","current":-7.104995,"twenty":-26.248892,"median":-14.119017,"eighty":-11.287262,"marketCap":2903463713},{"date":"2024-11-01","current":-6.615271,"twenty":-26.199776,"median":-13.881638,"eighty":-9.764235,"marketCap":2705160134},{"date":"2024-11-08","current":-6.847628,"twenty":-26.169892,"median":-13.803075,"eighty":-8.441853,"marketCap":2787474827},{"date":"2024-11-15","current":-7.078843,"twenty":-26.118271,"median":-13.690467,"eighty":-8.248986,"marketCap":2851081635},{"date":"2024-11-22","current":-6.784782,"twenty":-26.059844,"median":-13.633178,"eighty":-7.853303,"marketCap":2731351173},{"date":"2024-11-29","current":-5.682581,"twenty":-26.04047,"median":-13.539989,"eighty":-7.45767,"marketCap":2286103516},{"date":"2024-12-06","current":-5.602773,"twenty":-26.037499,"median":-13.514674,"eighty":-7.358253,"marketCap":2248687746},{"date":"2024-12-13","current":-6.121403,"twenty":-26.029477,"median":-13.45004,"eighty":-7.218028,"marketCap":2451992323},{"date":"2024-12-20","current":-5.137492,"twenty":-25.962318,"median":-13.411134,"eighty":-7.087735,"marketCap":2048757705},{"date":"2024-12-27","current":-4.957491,"twenty":-25.887099,"median":-13.400213,"eighty":-7.078006,"marketCap":1975442320},{"date":"2025-01-03","current":-5.238569,"twenty":-25.753577,"median":-13.368079,"eighty":-6.925822,"marketCap":2089488475},{"date":"2025-01-10","current":-5.002231,"twenty":-25.638014,"median":-13.3526,"eighty":-6.765934,"marketCap":1987661551},{"date":"2025-01-17","current":-5.018682,"twenty":-25.5579,"median":-13.317479,"eighty":-6.665777,"marketCap":1995807705},{"date":"2025-01-24","current":-5.323319,"twenty":-25.548224,"median":-13.283546,"eighty":-6.596451,"marketCap":2130219244},{"date":"2025-01-28","current":-5.224689,"twenty":-25.503236,"median":-13.282823,"eighty":-6.532117,"marketCap":2101707706},{"date":"2025-02-07","current":-5.549725,"twenty":-25.42477,"median":-13.246663,"eighty":-6.254752,"marketCap":2219826937},{"date":"2025-02-14","current":-5.930475,"twenty":-25.395104,"median":-13.220128,"eighty":-6.076947,"marketCap":2366457707},{"date":"2025-02-21","current":-6.375256,"twenty":-25.366564,"median":-13.201126,"eighty":-6.054191,"marketCap":2557892324},{"date":"2025-02-28","current":-5.632443,"twenty":-25.318672,"median":-13.116805,"eighty":-5.974648,"marketCap":2252411553},{"date":"2025-03-07","current":-5.782376,"twenty":-25.249925,"median":-13.099044,"eighty":-5.827424,"marketCap":2321653861},{"date":"2025-03-14","current":-4.421401,"twenty":-25.219975,"median":-13.087912,"eighty":-5.725677,"marketCap":1775861550},{"date":"2025-03-21","current":-4.778207,"twenty":-25.207536,"median":-13.071662,"eighty":-5.66584,"marketCap":1918419243},{"date":"2025-03-28","current":-6.735516,"twenty":-25.163684,"median":-13.026305,"eighty":-5.651503,"marketCap":2276850015},{"date":"2025-04-03","current":-7.956153,"twenty":-25.0977,"median":-13.01303,"eighty":-5.66026,"marketCap":2684157710},{"date":"2025-04-11","current":-6.344288,"twenty":-25.036833,"median":-12.972072,"eighty":-5.68428,"marketCap":2126146167},{"date":"2025-04-17","current":-6.122985,"twenty":-24.972615,"median":-12.844749,"eighty":-5.691075,"marketCap":2056903859},{"date":"2025-04-25","current":-8.576896,"twenty":-24.895951,"median":-12.836736,"eighty":-5.703559,"marketCap":2883738480},{"date":"2025-05-02","current":-7.700417,"twenty":-24.872853,"median":-12.82514,"eighty":-5.710649,"marketCap":2594550017},{"date":"2025-05-09","current":-7.730765,"twenty":-24.846191,"median":-12.683619,"eighty":-5.725677,"marketCap":2623061555},{"date":"2025-05-16","current":-8.311097,"twenty":-24.799485,"median":-12.12195,"eighty":-5.751942,"marketCap":2843007711},{"date":"2025-05-23","current":-11.289802,"twenty":-24.776462,"median":-11.940532,"eighty":-5.771038,"marketCap":3873496179},{"date":"2025-05-30","current":-15.223569,"twenty":-24.763734,"median":-11.970101,"eighty":-5.797425,"marketCap":5246123111},{"date":"2025-06-06","current":-16.623143,"twenty":-24.617548,"median":-12.331836,"eighty":-5.827424,"marketCap":5743038499},{"date":"2025-06-13","current":-15.603079,"twenty":-24.258649,"median":-12.701975,"eighty":-5.862056,"marketCap":5392753881},{"date":"2025-06-20","current":-14.878015,"twenty":-24.00727,"median":-12.82804,"eighty":-5.90109,"marketCap":5132076957},{"date":"2025-06-27","current":-13.023121,"twenty":-23.933348,"median":-12.837907,"eighty":-5.91626,"marketCap":4504823106},{"date":"2025-07-04","current":-14.906416,"twenty":-23.89321,"median":-12.895238,"eighty":-5.935244,"marketCap":5156515418},{"date":"2025-07-11","current":-12.022018,"twenty":-23.818294,"median":-12.972072,"eighty":-5.957179,"marketCap":4154538489},{"date":"2025-07-18","current":-12.975089,"twenty":-23.597552,"median":-12.895238,"eighty":-5.971632,"marketCap":4480384645},{"date":"2025-07-25","current":-12.316929,"twenty":-23.410778,"median":-12.839078,"eighty":-5.984465,"marketCap":4268584643},{"date":"2025-08-01","current":-12.109688,"twenty":-23.260279,"median":-12.895238,"eighty":-5.992729,"marketCap":4170830796},{"date":"2025-08-08","current":-13.046774,"twenty":-23.142239,"median":-12.972072,"eighty":-6.013995,"marketCap":4504823106},{"date":"2025-08-15","current":-15.594562,"twenty":-23.052783,"median":-12.982136,"eighty":-6.023266,"marketCap":5376461574},{"date":"2025-08-22","current":-14.245172,"twenty":-22.717488,"median":-13.011166,"eighty":-6.052989,"marketCap":4895838493},{"date":"2025-08-25","current":-14.555161,"twenty":-22.665631,"median":-13.01303,"eighty":-6.054191,"marketCap":5022103879}],"updateTime":1756219202419},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01541\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2546198007","title":"宜明昂科-B06月27日遭主力拋售1131.5萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546198007","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546198007?lang=zh_tw&edition=fundamental","pubTime":"2025-06-27 16:15","pubTimestamp":1751012134,"startTime":"0","endTime":"0","summary":"06月27日, 宜明昂科-B股价跌6.27%,报收11.06元,成交金额1.1亿元,换手率2.43%,振幅11.36%,量比2.58。宜明昂科-B今日主力资金净流出1131.5万元,连续3日净流出,上一交易日主力净流出2043.4万元。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为35.71%,平均跌幅为5.16%。该股近5个交易日下跌12.22%,主力资金累计净流出3374.2万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出4840.5万元,其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627172651a4c0dd11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627172651a4c0dd11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2546827195","title":"宜明昂科-B盤中異動 早盤股價大跌5.11%報12.640港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546827195","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546827195?lang=zh_tw&edition=fundamental","pubTime":"2025-06-26 11:02","pubTimestamp":1750906952,"startTime":"0","endTime":"0","summary":"2025年06月26日早盘11时02分,宜明昂科-B股票出现波动,股价大幅下挫5.11%。截至发稿,该股报12.640港元/股,成交量226.19万股,换手率0.57%,振幅9.76%。资金方面,该股资金流入769.295万港元,流出1788.41万港元。宜明昂科-B股票所在的生物技术行业中,整体跌幅为1.35%。其相关个股中,正大企业国际、华康生物医学、同源康医药-B涨幅较大,振幅较大的相关个股有北海康成-B、正大企业国际、同源康医药-B,振幅分别为24.18%、15.79%、11.98%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626110232a71e11b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626110232a71e11b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2545006874","title":"宜明昂科-B06月24日主力淨流入167.1萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2545006874","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545006874?lang=zh_tw&edition=fundamental","pubTime":"2025-06-24 16:15","pubTimestamp":1750752928,"startTime":"0","endTime":"0","summary":"06月24日, 宜明昂科-B股价涨2.56%,报收12.80元,成交金额5232.5万元,换手率1.01%,振幅8.33%,量比1.19。宜明昂科-B今日主力资金净流入167.1万元,上一交易日主力净流出112.3万元。该股近5个交易日上涨2.73%,主力资金累计净流出250.2万元;近20日主力资金累计净流出232.6万元,其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624172449a71af3ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624172449a71af3ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2545478430","title":"港股異動 | 宜明昂科-B(01541)漲超7% IMC-003/IMM72治療肺動脈高壓臨牀試驗獲國家藥監局批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2545478430","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545478430?lang=zh_tw&edition=fundamental","pubTime":"2025-06-24 10:29","pubTimestamp":1750732186,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,宜明昂科-B(01541)涨超7%,截至发稿,涨7.05%,报13.36港元,成交额1520.04万港元。消息面上,6月23日,宜明昂科-B发布公告,该集团获得中国国家药品监督管理局(“国家药监局”)有关启动IMC-003/IMM72治疗肺动脉高压(PAH) 的临床试验的新药临床试验(IND)批准。据介绍,IMC-003/IMM72为通过基因改造的新一代启动素受体IIA-Fc型(ActRIIA-Fc)融合蛋白,具有更高的活性及品质。集团拥有IMC-003/IMM72的全球知识产权以及开发及商业化权利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1308786.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03347","BK1141","BK1583","01541","BK1576","BK1161"],"gpt_icon":0},{"id":"2545457134","title":"宜明昂科-B盤中異動 股價大跌5.24%報11.940港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545457134","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545457134?lang=zh_tw&edition=fundamental","pubTime":"2025-06-23 09:32","pubTimestamp":1750642367,"startTime":"0","endTime":"0","summary":"2025年06月23日早盘09时32分,宜明昂科-B股票出现异动,股价大幅下挫5.24%。截至发稿,该股报11.940港元/股,成交量7.72万股,换手率0.02%,振幅5.40%。资金方面,该股资金流入45.6488万港元,流出41.028万港元。宜明昂科-B股票所在的生物技术行业中,整体涨幅为0.18%。其相关个股中,药捷安康-B、和铂医药-B、正大企业国际涨幅较大,振幅较大的相关个股有北海康成-B、药捷安康-B、宜明昂科-B,振幅分别为12.12%、9.89%、5.40%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623093247a717d531&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623093247a717d531&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2545561824","title":"宜明昂科-B:IMC-003/IMM72獲國家藥監局批准進行臨牀試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2545561824","media":"格隆汇资讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545561824?lang=zh_tw&edition=fundamental","pubTime":"2025-06-23 06:34","pubTimestamp":1750631667,"startTime":"0","endTime":"0","summary":"格隆汇6月23日丨宜明昂科-B(01541.HK)发布公告,集团获得中国国家药品监督管理局(“国家药监局”)有关启动IMC-003/IMM72治疗肺动脉高压(PAH)的临床试验的新药临床试验(IND)批准。IMC-003/IMM72为通过基因改造的新一代启动素受体IIA-Fc型(ActRIIA-Fc)融合蛋白,具有更高的活性及品质。集团拥有IMC-003/IMM72的全球知识产权以及开发及商业化权利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623063433978a577b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623063433978a577b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","01541","BK1576","BK1161","03347","BK1141"],"gpt_icon":0},{"id":"2544168900","title":"宜明昂科-B06月19日主力淨流出319.7萬元 散戶資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2544168900","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544168900?lang=zh_tw&edition=fundamental","pubTime":"2025-06-19 16:15","pubTimestamp":1750320933,"startTime":"0","endTime":"0","summary":"06月19日, 宜明昂科-B股价跌2.56%,报收12.20元,成交金额4105.7万元,换手率0.87%,振幅8.47%,量比0.64。宜明昂科-B今日主力资金净流出319.7万元,上一交易日主力净流入162.6万元。该股近5个交易日下跌11.89%,主力资金累计净流出1164.1万元;近20日主力资金累计净流入973.0万元,其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619173257a4b24d6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619173257a4b24d6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2544978638","title":"宜明昂科-B06月18日主力淨流入162.6萬元 散戶資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2544978638","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544978638?lang=zh_tw&edition=fundamental","pubTime":"2025-06-18 16:15","pubTimestamp":1750234525,"startTime":"0","endTime":"0","summary":"06月18日, 宜明昂科-B股价涨0.48%,报收12.52元,成交金额5053.0万元,换手率1.04%,振幅4.49%,量比0.74。宜明昂科-B今日主力资金净流入162.6万元,上一交易日主力净流出570.6万元。该股近5个交易日下跌12.01%,主力资金累计净流出789.5万元;近20日主力资金累计净流入3533.4万元,其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618173048a4b04090&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618173048a4b04090&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2543606630","title":"宜明昂科-B(01541):贖回及認購理財產品","url":"https://stock-news.laohu8.com/highlight/detail?id=2543606630","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543606630?lang=zh_tw&edition=fundamental","pubTime":"2025-06-16 22:40","pubTimestamp":1750084848,"startTime":"0","endTime":"0","summary":"智通财经APP讯,宜明昂科-B(01541)发布公告,公司已于2025年6月16日通知海通资产管理,以现金赎回2亿港元的海通产品,即其当时持有的全部海通产品,估计收益约为510.2万港元(即赎回事项产生的未经审计利息收入)。于赎回事项后,集团将不再持有海通资产管理任何尚未到期理财产品。此外,于2025年6月16日,公司同意向申万宏源证券(香港)认购金额为2.05亿港元的理财产品(申万产品)。认购事项由集团的内部盈余现金储备提供资金。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1305967.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2543678313","title":"宜明昂科-B06月16日主力淨流入216.1萬元 散戶資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2543678313","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543678313?lang=zh_tw&edition=fundamental","pubTime":"2025-06-16 16:15","pubTimestamp":1750061751,"startTime":"0","endTime":"0","summary":"06月16日, 宜明昂科-B股价涨1.96%,报收13.50元,成交金额3792.0万元,换手率0.72%,振幅6.95%,量比0.37。宜明昂科-B今日主力资金净流入216.1万元,上一交易日主力净流出652.6万元。该股近5个交易日下跌5.30%,主力资金累计净流出1230.7万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入4823.6万元,其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616173911a70bc6cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616173911a70bc6cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2543763375","title":"宜明昂科-B(01541)股價下跌8.023%,現價港幣$12.84","url":"https://stock-news.laohu8.com/highlight/detail?id=2543763375","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543763375?lang=zh_tw&edition=fundamental","pubTime":"2025-06-13 11:40","pubTimestamp":1749786000,"startTime":"0","endTime":"0","summary":"[下跌股]宜明昂科-B(01541) 股价在上午11:40比前收市价下跌8.023%,现股价为港币$12.84。至目前为止,今日最高价为$14.36,而最低价为$12.84。总成交量为492.6万股,总成交金额为港币$6.593千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131627024_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131627024_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2506132118/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2542567499","title":"不在港股通股價也狂飆,PD-(L)1/VEGF雙抗熱潮下,宜明昂科有“幾把刷子”?","url":"https://stock-news.laohu8.com/highlight/detail?id=2542567499","media":"Ofweek维科网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542567499?lang=zh_tw&edition=fundamental","pubTime":"2025-06-12 14:42","pubTimestamp":1749710532,"startTime":"0","endTime":"0","summary":"比如,IMM2510这款PD-L1/VEGF双抗产品有很大希望成为宜明昂科的“印钞机”。当然,就现阶段而言,创新药开发门槛颇高,PD-1/VEGF双抗领域的“拉锯战”也已经开启,宜明昂科实现产品价值充分兑现不是容易的事。截至2024年12月31日,宜明昂科已收取首付款及近期付款1500万美元。好消息是,除了PD-1/VEGF双抗,宜明昂科手头还有不少热门产品管线。来源:医药研究社原文标题 : 不在港股通股价也狂飙,PD-1/VEGF双抗热潮下,宜明昂科有“几把刷子”?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612144229977c3433&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612144229977c3433&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HSCEI","HSTECH","BK1161","01541"],"gpt_icon":1},{"id":"2542563921","title":"宜明昂科-B盤中異動 股價大漲5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542563921","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542563921?lang=zh_tw&edition=fundamental","pubTime":"2025-06-12 11:18","pubTimestamp":1749698319,"startTime":"0","endTime":"0","summary":"2025年06月12日早盘11时18分,宜明昂科-B股票出现异动,股价急速上涨5.03%。截至发稿,该股报15.040港元/股,成交量218.6万股,换手率0.55%,振幅6.84%。机构评级方面,在所有1家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。宜明昂科-B股票所在的生物技术行业中,整体涨幅为3.94%。宜明昂科-B公司简介:宜明昂科生物医药技术(上海)股份有限公司是一家主要从事测试生物技术研发的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612111840977bf7b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612111840977bf7b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2542200533","title":"宜明昂科-B盤中異動 早盤股價大跌5.18%報14.280港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542200533","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542200533?lang=zh_tw&edition=fundamental","pubTime":"2025-06-11 10:20","pubTimestamp":1749608400,"startTime":"0","endTime":"0","summary":"2025年06月11日早盘10时20分,宜明昂科-B股票出现波动,股价急速下跌5.18%。截至发稿,该股报14.280港元/股,成交量208.84万股,换手率0.53%,振幅8.76%。资金方面,该股资金流入912.296万港元,流出1987.31万港元。宜明昂科-B股票所在的生物技术行业中,整体跌幅为0.83%。其相关个股中,帝王国际投资、博安生物、科济药业-B涨幅较大,振幅较大的相关个股有北海康成-B、科济药业-B、中国抗体-B,振幅分别为18.99%、11.65%、10.71%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611102000a4a2c1fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611102000a4a2c1fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2542809081","title":"宜明昂科-B(01541):吳諸麗獲委任為首席醫學官","url":"https://stock-news.laohu8.com/highlight/detail?id=2542809081","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542809081?lang=zh_tw&edition=fundamental","pubTime":"2025-06-09 16:35","pubTimestamp":1749458100,"startTime":"0","endTime":"0","summary":"智通财经APP讯,宜明昂科-B(01541)发布公告,吴诸丽医生获委任为集团的首席医学官,自2025年6月9日起生效,负责公司临床团队搭建及管理、临床试验研究及临床开发与注册。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1302893.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2542287814","title":"宜明昂科-B盤中異動 快速上漲5.39%報14.860港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542287814","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542287814?lang=zh_tw&edition=fundamental","pubTime":"2025-06-09 09:37","pubTimestamp":1749433055,"startTime":"0","endTime":"0","summary":"2025年06月09日早盘09时37分,宜明昂科-B股票出现波动,股价快速上涨5.39%。截至发稿,该股报14.860港元/股,成交量60.02万股,换手率0.15%,振幅2.70%。资金方面,该股资金流入545.895万港元,流出235.583万港元。宜明昂科-B股票所在的生物技术行业中,整体涨幅为0.14%。其相关个股中,中国抗体-B、金斯瑞生物科技、药明巨诺-B涨幅较大,振幅较大的相关个股有中国抗体-B、基石药业-B、荃信生物-B,振幅分别为15.96%、6.39%、6.22%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609093735a6ffbedb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609093735a6ffbedb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2541470833","title":"宜明昂科-B午後漲超9% IMM0306今年有望實現大金額BD IMM2510數據優秀","url":"https://stock-news.laohu8.com/highlight/detail?id=2541470833","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541470833?lang=zh_tw&edition=fundamental","pubTime":"2025-06-06 14:58","pubTimestamp":1749193096,"startTime":"0","endTime":"0","summary":"宜明昂科-b午后涨超9%,截至发稿,涨8.68%,报14.28港元,成交额6045.06万港元。IMM0306治疗自身免疫性疾病临床试验目前进行Ib期爬坡试验,目前SLE的试验有10例患者入组,试验顺利推进,应答情况较好,有望于6月出数据。目前全球治疗自身免疫性疾病的生物创新药物紧缺,有望受到MNC青睐,今年有望实现大金额BD。目前全球有两款CD47×CD20双特异性抗体/融合蛋白正在开发中,而IMM0306是全球首款进入临床试验阶段的。该行指出,IMM2510近期披露的数据也非常优秀。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606150601a49c7fa0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606150601a49c7fa0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2541838294","title":"【券商聚焦】國元國際予宜明昂科(01541)買入評級 指CD47CD20雙抗有望成為自免領域重磅藥物","url":"https://stock-news.laohu8.com/highlight/detail?id=2541838294","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541838294?lang=zh_tw&edition=fundamental","pubTime":"2025-06-06 14:41","pubTimestamp":1749192101,"startTime":"0","endTime":"0","summary":"自2025年3月底以来,已有30多名NSCLC患者入组。初步安全性和有效性结果预计于2025年下半年公布。IMM01与PD-1抗体联用针对复发难治性经典霍奇金淋巴瘤,ORR达69.7%,CR达24.2%,18个月整体生存率达91.6%。该机构指,CD47CD20双抗临床顺利推进,有望成为自免领域重磅药物,预计公司2025至2027年 实现收入2.01 / 1.22/ 3.12亿元人民币;归母净利润-2.64 / -3.43/ -1.89 亿元人民币。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/MWIyNWQwZjQ4NTQyNjI4OTI5NDE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWIyNWQwZjQ4NTQyNjI4OTI5NDE=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1960014","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541"],"gpt_icon":0},{"id":"2541833878","title":"宜明昂科-B盤中異動 下午盤急速上漲5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541833878","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541833878?lang=zh_tw&edition=fundamental","pubTime":"2025-06-06 14:35","pubTimestamp":1749191752,"startTime":"0","endTime":"0","summary":"2025年06月06日下午盘14时35分,宜明昂科-B股票出现异动,股价急速拉升5.18%。截至发稿,该股报13.820港元/股,成交量281.56万股,换手率0.71%,振幅8.52%。宜明昂科-B股票所在的生物技术行业中,整体跌幅为0.43%。其相关个股中,华领医药-B、金斯瑞生物科技、宜明昂科-B涨幅较大,振幅较大的相关个股有北海康成-B、中国抗体-B、帝王国际投资,振幅分别为20.69%、14.41%、10.81%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060614355297740597&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060614355297740597&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2541401625","title":"宜明昂科-B盤中異動 快速拉昇5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541401625","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541401625?lang=zh_tw&edition=fundamental","pubTime":"2025-06-05 09:51","pubTimestamp":1749088307,"startTime":"0","endTime":"0","summary":"2025年06月05日早盘09时51分,宜明昂科-B股票出现异动,股价急速上涨5.02%。截至发稿,该股报13.800港元/股,成交量79.3万股,换手率0.20%,振幅5.02%。宜明昂科-B股票所在的生物技术行业中,整体跌幅为1.11%。宜明昂科-B公司简介:宜明昂科生物医药技术(上海)股份有限公司是一家主要从事测试生物技术研发的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605095147950f522b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605095147950f522b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":191,"code":"91000000","status":"200"}]}}